65219-622-10 : NDC 2026 Code

65219-622-10 : Acyclovir ( Acyclovir )

Additionally :

You can get information about “65219-622-10” NDC code in 65219-622-10 in HTML format

HTML | 65219-622-10 in TXT (Plain Text) format

TXT | 65219-622-10 in PDF (Portable Document Format)

PDF | 65219-622-10 in XML format

XML formats.

NDC Code : 65219-622-10 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "65219-622-10",
    "PackageDescription": "10 VIAL in 1 CARTON (65219-622-10)  / 10 mL in 1 VIAL (65219-622-02) ",
    "NDC11Code": "65219-0622-10",
    "ProductNDC": "65219-622",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Acyclovir",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Acyclovir",
    "DosageFormName": "INJECTION, SOLUTION",
    "RouteName": "INTRAVENOUS",
    "StartMarketingDate": "20241216",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA215404",
    "LabelerName": "Fresenius Kabi USA, LLC",
    "SubstanceName": "ACYCLOVIR SODIUM",
    "StrengthNumber": "50",
    "StrengthUnit": "mg/mL",
    "Pharm_Classes": "DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2024-12-17",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20241216",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}